TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 35 filers reported holding TRANSLATE BIO INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $24,303,000 | +22.5% | 2,437,603 | 0.0% | 10.06% | +59.2% |
Q4 2019 | $19,842,000 | -17.9% | 2,437,603 | 0.0% | 6.32% | -15.3% |
Q3 2019 | $24,157,000 | -21.5% | 2,437,603 | 0.0% | 7.46% | -5.0% |
Q2 2019 | $30,787,000 | -38.0% | 2,437,603 | -50.0% | 7.85% | -25.2% |
Q1 2019 | $49,678,000 | +171.7% | 4,875,206 | +100.0% | 10.50% | -22.5% |
Q4 2018 | $18,282,000 | -25.0% | 2,437,603 | +0.0% | 13.56% | +17.5% |
Q3 2018 | $24,376,000 | -20.9% | 2,437,601 | 0.0% | 11.53% | -49.3% |
Q2 2018 | $30,836,000 | – | 2,437,601 | – | 22.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 1,872,115 | $30,871,000 | 5.70% |
FRAZIER MANAGEMENT LLC | 2,182,789 | $35,994,000 | 2.89% |
Baupost Group | 18,044,239 | $295,810,000 | 2.36% |
RTW INVESTMENTS, LP | 4,382,199 | $72,262,000 | 1.13% |
DAFNA Capital Management LLC | 225,393 | $3,717,000 | 0.88% |
Camber Capital Management LP | 1,150,000 | $18,964,000 | 0.65% |
EcoR1 Capital, LLC | 596,900 | $9,843,000 | 0.44% |
Alpha Paradigm Partners, LLC | 50,393 | $831,000,000 | 0.32% |
Birchview Capital, LP | 30,000 | $495,000 | 0.29% |
Artal Group S.A. | 1,000,000 | $16,490,000 | 0.29% |